Display search results for ** instead (1547 products)
14 Feb 2002  |  Global
20 Jan 2014  |  Global
As 2013 transitions into 2014, the Manufacturing Leadership team offers 10 issues that should be top of mind for manufacturers in the new year.
30 Apr 2014  |  Global
This issue of Vital Signs, released on May 1, 2014, discusses the mega deals brewing in the pharma/biotech industry, Pfizer Incs Xalkori for non-small cell lung cancer, Novartis halt on RNAi development efforts, the high-ranked Malaysian healthcare system, Roches acquisition of IQuums Liat Analyzer, and Bio-Rads acquisition of GnuBio.
02 Jun 2014  |  Global
This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.
20 Jun 2014  |  Global
Francis Bitonti, Principle and Founder of the Francis Bitonti Studio, blew a few minds at the Manufacturing Leadership Summit held in Palm Beach, Florida in June 2014, as he walked us through how his studio uses a blend of computer-driven techniques and cutting-edge manufacturing technologies to design, construct, and manufacture some fairly other ...
USD 187.50 save 25 %
01 Jul 2014  |  Global
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
11 Jul 2014  |  Global
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
13 Jul 2014  |  Global
The high tech industry and its supporting cast of research firms and consultancies are all abuzz these days with the idea of the 'Internet of Things'. The trend they think they have identified is that every conceivable physical object in the world will likely become IP-enabled, leading to a massive new era of innovation with significant new opportu...
USD 187.50 save 25 %
04 Aug 2014  |  Global
This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.
03 Sep 2014  |  Global
This issue of Vital Signs, released on September 3, 2014, discusses Thermo Fisher Scientifics divestment of laboratory equipment company Cole-Parmer to GTCR, the increasing use of large animal biotechnology in human health applications, the collaboration of Life Technologies and RainTree Oncology Services, the agreement between Ventana and Quintile...